-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

IgG-4 Disease for the Hematologist

Program: Education Program
Session: Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation
Hematology Disease Topics & Pathways:
Research, Antibody Therapy, Clinical Research, Education, Diseases, Immune Disorders, Treatment Considerations, Biological therapies, Lymphoid Malignancies
Saturday, December 7, 2024, 9:30 AM-10:45 AM

Luke Y. C. Chen, MD, MEd

Division of Hematology, Dalhousie University, Halifax, NS, Canada

Disclosures: No relevant conflicts of interest to declare.

OffLabel Disclosure: off label use of B cell depletion therapy (rituximab, obexelimab) will be discussed as IgG4-RD is a rare disease.

See more of: Not All Lymphadenopathy is Lymphoma: Lymphoproliferative Diseases of Immune Dysregulation
See more of: Education Program
<< Previous Presentation | Next Presentation >>